NB
Namrata Baldwa
About Namrata Baldwa
Data last updated:
Namrata Baldwa is a Designated Partner at Impero Exim Llp (since 2024). The companies operate in Pharma. Earlier, Namrata Baldwa was a Director at Shilpa Medicare Limited (2015–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Impero Exim Llp ACF-2028 | Designated Partner | 01 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shilpa Medicare Limited L85110KA1987PLC008739 | Director | 28 Feb 2015 | 1987 | ₹1,310 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Namrata Baldwa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manas Baldwa | 10485602 | Impero Exim Llp | Designated Partner |
| Saket Baldwa | 10485603 | Impero Exim Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Namrata Baldwa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namrata Baldwa
Namrata Baldwa currently holds 1 directorship: Impero Exim Llp (Designated Partner, since 01 Apr 2024).
Namrata Baldwa was first appointed on 28 Feb 2015 as Director at Shilpa Medicare Limited. The most recent appointment on record is 01 Apr 2024 at Impero Exim Llp.
Namrata Baldwa held 1 earlier board appointment: Shilpa Medicare Limited (Director, 28 Feb 2015 to 27 May 2019).
The current boards of Namrata Baldwa's companies include Manas Baldwa (Impero Exim Llp), Saket Baldwa (Impero Exim Llp).